首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Solution of the multistep pathway for assembly of corynanthean strychnos iboga and aspidosperma monoterpenoid indole alkaloids from 19E-geissoschizine
【2h】

Solution of the multistep pathway for assembly of corynanthean strychnos iboga and aspidosperma monoterpenoid indole alkaloids from 19E-geissoschizine

机译:从19E-geissoschizine组装多头孢菌烷马兜铃虫伊博加和曲霉单萜类吲哚生物碱的多步途径的解决方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Monoterpenoid indole alkaloids (MIAs) possess a diversity of alkaloid skeletons whose biosynthesis is poorly understood. A bioinformatic search of candidate genes, combined with their virus-induced gene silencing, targeted MIA profiling and in vitro/in vivo pathway reconstitution identified and functionally characterized six genes as well as a seventh enzyme reaction required for the conversion of 19E-geissoschizine to tabersonine and catharanthine. The involvement of pathway intermediates in the formation of four MIA skeletons is described, and the role of stemmadenine-O-acetylation in providing necessary reactive substrates for the formation of iboga and aspidosperma MIAs is described. The results enable the assembly of complex dimeric MIAs used in cancer chemotherapy and open the way to production of many other biologically active MIAs that are not easily available from nature.
机译:单萜类吲哚生物碱(MIA)具有生物合成了解甚少的多种生物碱骨架。对候选基因进行生物信息学搜索,结合其病毒诱导的基因沉默,有针对性的MIA分析和体外/体内途径重构,鉴定和功能表征了6个基因以及19E-geissoschizine转化为tabersonine所需的第七种酶反应和catharanthine。描述了途径中间体在四个MIA骨架形成中的参与,并描述了茎马丹宁-O-乙酰化在提供必要的反应性底物以形成iboga和曲霉精子MIA中的作用。结果使得能够组装用于癌症化学疗法的复杂二聚体MIA,并开辟了生产许多其他生物活性MIA的途径,而这些天然MIA很难从自然界获得。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号